Welcome to Emergent BioSolutions Inc. fourth quarter 2024 earnings conference call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question ...
14d
Despite a dip in Q4 revenue, Emergent BioSolutions Inc (EBS) showcases significant profitability improvements and strategic positioning for future growth.
$EBS insiders have traded $EBS stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales. Here’s a ...
GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Emergent Biosolutions Inc. (EBS) on Monday reported a loss of $31.3 million in its fourth quarter. The Gaithersburg, Maryland-based company said it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback